• 13Dec

    Part I in BeginingFarmers.org’s series about corporate domination, consolidation, and possible antitrust violations in the agriculture sector.

    See Part II HERE; See Part III HERE; See Part IV HERE

    Associated Press IMPACT: Monsanto seed business role revealed : Secret documents detail Monsanto’s seed business domination amid antitrust fears

    Original article at: http://hosted.ap.org/dynamic/stories/U/US_SEED_GIANT?SITE=SCAND&SECTION=HOME&TEMPLATE=DEFAULT

    CHRISTOPHER LEONARD
    AP News
    Dec 13, 2009 13:45 EST

    Confidential contracts detailing Monsanto Co.’s business practices
    reveal how the world’s biggest seed developer is squeezing
    competitors, controlling smaller seed companies and protecting its
    dominance over the multibillion-dollar market for genetically altered
    crops, an Associated Press investigation has found.

    With Monsanto’s patented genes being inserted into roughly 95 percent
    of all soybeans and 80 percent of all corn grown in the U.S., the
    company also is using its wide reach to control the ability of new
    biotech firms to get wide distribution for their products, according
    to a review of several Monsanto licensing agreements and dozens of
    interviews with seed industry participants, agriculture and legal
    experts.

    Declining competition in the seed business could lead to price hikes
    that ripple out to every family’s dinner table. That’s because the
    corn flakes you had for breakfast, soda you drank at lunch and beef
    stew you ate for dinner likely were produced from crops grown with
    Monsanto’s patented genes.

    Monsanto’s methods are spelled out in a series of confidential
    commercial licensing agreements obtained by the AP. The contracts, as
    long as 30 pages, include basic terms for the selling of engineered
    crops resistant to Monsanto’s Roundup herbicide, along with shorter
    supplementary agreements that address new Monsanto traits or other
    contract amendments.
    The company has used the agreements to spread its technology — giving
    some 200 smaller companies the right to insert Monsanto’s genes in
    their separate strains of corn and soybean plants. But, the AP found,
    access to Monsanto’s genes comes at a cost, and with plenty of strings
    attached.

    For example, one contract provision bans independent companies from
    breeding plants that contain both Monsanto’s genes and the genes of
    any of its competitors, unless Monsanto gives prior written permission
    — giving Monsanto the ability to effectively lock out competitors from
    inserting their patented traits into the vast share of U.S. crops that
    already contain Monsanto’s genes.

    Monsanto’s business strategies and licensing agreements are being
    investigated by the U.S. Department of Justice and at least two state
    attorneys general, who are trying to determine if the practices
    violate U.S. antitrust laws. The practices also are at the heart of
    civil antitrust suits filed against Monsanto by its competitors,
    including a 2004 suit filed by Syngenta AG that was settled with an
    agreement and ongoing litigation filed this summer by DuPont in
    response to a Monsanto lawsuit.

    The suburban St. Louis-based agricultural giant said it’s done nothing
    wrong.
    “We do not believe there is any merit to allegations about our
    licensing agreement or the terms within,” said Monsanto spokesman Lee
    Quarles. He said he couldn’t comment on many specific provisions of
    the agreements because they are confidential and the subject of
    ongoing litigation.
    “Our approach to licensing (with) many companies is pro-competitive
    and has enabled literally hundreds of seed companies, including all of
    our major direct competitors, to offer thousands of new seed products
    to farmers,” he said.

    The benefit of Monsanto’s technology for farmers has been undeniable,
    but some of its major competitors and smaller seed firms claim the
    company is using strong-arm tactics to further its control.

    “We now believe that Monsanto has control over as much as 90 percent
    of (seed genetics). This level of control is almost unbelievable,”
    said Neil Harl, agricultural economist at Iowa State University who
    has studied the seed industry for decades. “The upshot of that is that
    it’s tightening Monsanto’s control, and makes it possible for them to
    increase their prices long term. And we’ve seen this happening the
    last five years, and the end is not in sight.”

    At issue is how much power one company can have over seeds, the
    foundation of the world’s food supply. Without stiff competition,
    Monsanto could raise its seed prices at will, which in turn could
    raise the cost of everything from animal feed to wheat bread and
    cookies.

    The price of seeds is already rising. Monsanto increased some corn
    seed prices last year by 25 percent, with an additional 7 percent hike
    planned for corn seeds in 2010. Monsanto brand soybean seeds climbed
    28 percent last year and will be flat or up 6 percent in 2010, said
    company spokeswoman Kelli Powers.

    Monsanto’s broad use of licensing agreements has made its biotech
    traits among the most widely and rapidly adopted technologies in
    farming history. These days, when farmers buy bags of seed with
    obscure brand names like AgVenture or M-Pride Genetics, they are
    paying for Monsanto’s licensed products.

    One of the numerous provisions in the licensing agreements is a ban on
    mixing genes — or “stacking” in industry lingo — that enhance
    Monsanto’s power.

    One contract provision likely helped Monsanto buy 24 independent seed
    companies throughout the Farm Belt over the last few years: that corn
    seed agreement says that if a smaller company changes ownership, its
    inventory with Monsanto’s traits “shall be destroyed immediately.”
    Another provision from contracts earlier this decade_ regarding
    rebates — also help explain Monsanto’s rapid growth as it rolled out
    new products.

    One contract gave an independent seed company deep discounts if the
    company ensured that Monsanto’s products would make up 70 percent of
    its total corn seed inventory. In its 2004 lawsuit, Syngenta called
    the discounts part of Monsanto’s “scorched earth campaign” to keep
    Syngenta’s new traits out of the market.

    Quarles said the discounts were used to entice seed companies to carry
    Monsanto products when the technology was new and farmers hadn’t yet
    used it. Now that the products are widespread, Monsanto has
    discontinued the discounts, he said.
    The Monsanto contracts reviewed by the AP prohibit seed companies from
    discussing terms, and Monsanto has the right to cancel deals and wipe
    out the inventory of a business if the confidentiality clauses are
    violated.
    Thomas Terral, chief executive officer of Terral Seed in Louisiana,
    said he recently rejected a Monsanto contract because it put too many
    restrictions on his business. But Terral refused to provide the
    unsigned contract to AP or even discuss its contents because he was
    afraid Monsanto would retaliate and cancel the rest of his agreements.
    “I would be so tied up in what I was able to do that basically I would
    have no value to anybody else,” he said. “The only person I would have
    value to is Monsanto, and I would continue to pay them millions in
    fees.”
    Independent seed company owners could drop their contracts with
    Monsanto and return to selling conventional seed, but they say it
    could be financially ruinous. Monsanto’s Roundup Ready gene has become
    the industry standard over the last decade, and small companies fear
    losing customers if they drop it. It also can take years of breeding
    and investment to mix Monsanto’s genes into a seed company’s product
    line, so dropping the genes can be costly.
    Monsanto acknowledged that U.S. Department of Justice lawyers are
    seeking documents and interviewing company employees about its
    marketing practices. The DOJ wouldn’t comment.
    A spokesman for Iowa Attorney General Tom Miller said the office is
    examining possible antitrust violations. Additionally, two sources
    familiar with an investigation in Texas said state Attorney General
    Greg Abbott’s office is considering the same issues. States have the
    authority to enforce federal antitrust law, and attorneys general are
    often involved in such cases.
    Monsanto chairman and chief executive officer Hugh Grant told
    investment analysts during a conference call this fall that the price
    increases are justified by the productivity boost farmers get from the
    company’s seeds. Farmers and seed company owners agree that Monsanto’s
    technology has boosted yields and profits, saving farmers time they
    once spent weeding and money they once spent on pesticides.
    But recent price hikes have still been tough to swallow on the farm.
    “It’s just like I got hit with bad weather and got a poor yield. It
    just means I’ve got less in the bottom line,” said Markus Reinke, a
    corn and soybean farmer near Concordia, Mo. who took over his family’s
    farm in 1965. “They can charge because they can do it, and get away
    with it. And us farmers just complain, and shake our heads and go
    along with it.”
    Any Justice Department case against Monsanto could break new ground in
    balancing a company’s right to control its patented products while
    protecting competitors’ right to free and open competition, said Kevin
    Arquit, former director of the Federal Trade Commission competition
    bureau and now a antitrust attorney with Simpson Thacher & Bartlett
    LLP in New York.
    “These are very interesting issues, and not just for the companies,
    but for the Justice Department,” Arquit said. “They’re in an area
    where there is uncertainty in the law and there are consumer welfare
    implications and government policy implications for whatever the
    result is.”
    Other seed companies have followed Monsanto’s lead by including
    restrictive clauses in their licensing agreements, but their products
    only penetrate smaller segments of the U.S. seed market. Monsanto’s
    Roundup Ready gene, on the other hand, is in such a wide array of
    crops that its licensing agreements can have a massive effect on the
    rules of the marketplace.
    Monsanto was only a niche player in the seed business just 12 years
    ago. It rose to the top thanks to innovation by its scientists and
    aggressive use of patent law by its attorneys.
    First came the science, when Monsanto in 1996 introduced the world’s
    first commercial strain of genetically engineered soybeans. The
    Roundup Ready plants were resistant to the herbicide, allowing farmers
    to spray Roundup whenever they wanted rather than wait until the
    soybeans had grown enough to withstand the chemical.
    The company soon released other genetically altered crops, such as
    corn plants that produced a natural pesticide to ward off bugs. While
    Monsanto had blockbuster products, it didn’t yet have a big foothold
    in a seed industry made up of hundreds of companies that supplied
    farmers.
    That’s where the legal innovations came in, as Monsanto became among
    the first to widely patent its genes and gain the right to strictly
    control how they were used. That control let it spread its technology
    through licensing agreements, while shaping the marketplace around
    them.
    Back in the 1970s, public universities developed new traits for corn
    and soybean seeds that made them grow hardy and resist pests. Small
    seed companies got the traits cheaply and could blend them to breed
    superior crops without restriction. But the agreements give Monsanto
    control over mixing multiple biotech traits into crops.
    The restrictions even apply to taxpayer-funded researchers.
    Roger Boerma, a research professor at the University of Georgia, is
    developing specialized strains of soybeans that grow well in
    southeastern states, but his current research is tangled up in such
    restrictions from Monsanto and its competitors.
    “It’s made one level of our life incredibly challenging and
    difficult,” Boerma said.
    The rules also can restrict research. Boerma halted research on a line
    of new soybean plants that contain a trait from a Monsanto competitor
    when he learned that the trait was ineffective unless it could be
    mixed with Monsanto’s Roundup Ready gene.
    Boerma said he hasn’t considered asking Monsanto’s permission to mix
    its traits with the competitor’s trait.
    “I think the co-mingling of their trait technology with another
    company’s trait technology would likely be a serious problem for
    them,” he said.
    Quarles pointed out that Monsanto has signed agreements with several
    companies allowing them to stack their traits with Monsanto’s. After
    Syngenta settled its lawsuit, for example, the companies struck a
    broad cross-licensing accord.
    At the same time, Monsanto’s patent rights give it the authority to
    say how independent companies use its traits, Quarles said.
    “Please also keep in mind that, as the (intellectual property
    developer), it is our right to determine who will obtain rights to our
    technology and for what purpose,” he said.
    Monsanto’s provision requiring companies to destroy seeds containing
    Monsanto’s traits if a competitor buys them prohibited DuPont or other
    big firms from bidding against Monsanto when it snapped up two dozen
    smaller seed companies over the last five years, said David Boies, a
    lawyer representing DuPont who previously was a prosecutor on the
    federal antitrust case against Microsoft Corp.
    Competitive bids from companies like DuPont could have made it far
    more expensive for Monsanto to bring the smaller companies into its
    fold. But that contract provision prevented bidding wars, according to
    DuPont.
    “If the independent seed company is losing their license and has to
    destroy their seeds, they’re not going to have anything, in effect, to
    sell,” Boies said. “It requires them to destroy things — destroy
    things they paid for — if they go competitive. That’s exactly the kind
    of restriction on competitive choice that the antitrust laws outlaw.”
    Quarles said some of the Monsanto contracts let companies sell their
    inventory for a period of time, rather than be required to destroy it.
    Seed companies also don’t have to pay royalty fees on the bags of seed
    they destroyed.
    “Simply put, it was designed to facilitate early adoption of the
    technology,” he said.
    Some independent seed company owners say they feel increasingly
    pinched as Monsanto cements its leadership in the industry.
    “They have the capital, they have the resources, they own lots of
    companies, and buying more. We’re small town, they’re Wall Street,”
    said Bill Cook, co-owner of M-Pride Genetics seed company in Garden
    City, Mo., who also declined to discuss or provide the agreements.
    “It’s very difficult to compete in this environment against companies
    like Monsanto.”
    Source: AP News

    • StumbleUpon
    • Share/Bookmark

5 Responses

WP_Floristica

Leave a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.

Get Adobe Flash playerPlugin by wpburn.com wordpress themes

Categories

Search

Become a Fan:

Beginning Farmers

Promote Your Page Too